Buscopan (Hyoscine Butylbromide) Use in Treating Smooth Muscle Spasms
Buscopan (hyoscine butylbromide) is an antimuscarinic antispasmodic medication primarily used to relieve abdominal pain associated with gastrointestinal smooth muscle spasms, with demonstrated efficacy in reducing cramping through its anticholinergic action on muscarinic receptors in the GI tract.
Mechanism of Action
Hyoscine butylbromide works through:
- Anticholinergic effects with high affinity for muscarinic receptors on gastrointestinal smooth muscle cells 1
- Blockade of muscarinic receptors in the GI tract, resulting in smooth muscle relaxation and spasmolytic effects
- Binding to nicotinic receptors, producing a ganglion-blocking effect 1
- Concentration-dependent inhibition of smooth muscle activity, particularly effective against spasticity induced by cholinergic stimulation 2
Clinical Applications
Primary Indications
- Gastrointestinal smooth muscle spasms
Secondary Uses
Diagnostic and therapeutic procedures
Other applications
Dosage and Administration
Oral Administration
- Standard dose: 10-20 mg, 3-4 times daily 3
- For acute spasms: 20 mg as needed
Parenteral Administration
- Intravenous: 20-40 mg for acute spasms 4
- Onset of action: Within 10 minutes when given intravenously 4
- Duration of effect: Approximately 30 minutes to 2 hours
Efficacy
- Pain reduction of 42-78% observed in biliary colic within 30 minutes after a single IV injection of 20 mg 4
- Approximately 90% of patients with renal colic showed good to moderate analgesic responses after 30 minutes of IV administration 4
- Meta-analysis of antispasmodics in IBS showed significant improvement in global symptoms and abdominal pain compared to placebo 3
Advantages Over Other Antispasmodics
- As a quaternary ammonium compound, it does not cross the blood-brain barrier, minimizing central nervous system effects 1, 4
- Low systemic bioavailability (<1%) after oral administration, with high tissue affinity for intestinal muscarinic receptors 1
- Remains available at the site of action in the intestine due to its high tissue affinity 1
- Different inhibitory effectiveness on various parts of the GI tract, with increasing sensitivity from the esophagus to the ileum 2
Safety Profile and Side Effects
Common Side Effects
- Typical anticholinergic effects:
- Dry mouth
- Blurred vision (temporary impairment of visual accommodation) 5
- Constipation
- Urinary retention
Safety Considerations
- Generally well tolerated due to minimal systemic absorption 1
- Minor abnormalities of near vision may occur in patients under 50 years, typically resolving within 12-21 minutes 5
- No significant impairment of distance vision or driving ability reported 5
- Self-limiting adverse events typical for anticholinergic drugs 4
Precautions and Contraindications
- Use with caution in:
- Glaucoma
- Prostatic hypertrophy
- Cardiac conditions
- Myasthenia gravis
- Elderly patients (increased sensitivity to anticholinergic effects)
Clinical Pearls
- Buscopan is more effective for spasms induced by cholinergic stimulation than those caused by high potassium concentrations 2
- The inhibitory effect shows a gradient of increasing sensitivity from the esophagus to the ileum 2
- Small doses (10-20 mg IV) are adequate for diagnostic procedures with minimal side effects 6
- For IBS, antispasmodics including hyoscine butylbromide are among the most frequently used over-the-counter treatments 3
Buscopan remains a valuable treatment option for patients with abdominal pain or discomfort associated with smooth muscle spasms, particularly in the gastrointestinal tract, with a favorable efficacy and safety profile.